Lactylation landscape of mitochondrial proteins in myocardial infarction

This study reveals that mitochondrial protein lactylation acts as a context-dependent metabolic regulator following myocardial infarction, where inhibiting lactate transport via MCT1 attenuates fibrosis and inflammation while partially restoring mitochondrial function by modulating redox balance and bioenergetics.

The Gist

Imagine your heart is a high-performance race car engine. Under normal conditions, it runs on premium fuel (fatty acids) to keep the car moving smoothly. But when a heart attack (Myocardial Infarction) happens, it's like the fuel line gets cut off. The engine is forced to switch to a backup generator running on cheap, inefficient fuel (sugar/glycolysis).

This backup fuel has a major side effect: it produces a lot of lactic acid (lactate), which is like exhaust fumes building up in the engine room. Usually, we think of this buildup as just a sign of the engine struggling. But this paper discovers something surprising: that lactic acid isn't just waste; it's actually a sticky note that gets pasted onto the engine's internal parts.

Here is the breakdown of the study using simple analogies:

1. The "Sticky Note" System (Lactylation)

Scientists recently discovered a new way cells communicate called lactylation. Think of it like a worker in a factory taking a piece of tape (lactate) and sticking it onto a specific machine part (a protein).

• The Discovery: In a heart attack, the engine room (mitochondria) gets covered in these sticky notes. The researchers mapped out exactly where these notes were placed. They found that the notes were stuck on the very parts of the engine responsible for generating power and managing the engine's temperature (redox balance).

2. The Traffic Jam (MCT1)

Normally, there's a gatekeeper door called MCT1 that lets lactic acid in and out of the engine room. When the heart is stressed, too much lactate piles up.

• The Experiment: The researchers tried closing this gate (using a drug called AZD3965) to see what would happen.
• The Surprise: You might think blocking the exit would make the engine explode from too much pressure. Instead, it changed where the sticky notes were placed. It didn't break the engine; it actually rearranged the notes in a way that helped some parts of the engine work better, even though the heart was still damaged.

3. The Aftermath: Less Rust, More Power

Even though the heart was still struggling to pump blood (global function was impaired), closing that gate had some amazing side effects:

• Less Rust: The heart had less scarring (fibrosis) and less inflammation. Think of it as the engine room staying cleaner and not rusting over as quickly.
• Better Spark: The engine's ability to breathe and generate energy actually improved. The "sticky notes" seemed to tell the engine to stop panicking and start running more efficiently.

4. The Big Picture

The study shows that lactate isn't just a villain. In the chaos of a heart attack, it acts like a smart manager trying to reorganize the factory floor.

• Old View: Lactate is bad waste that hurts the heart.
• New View: Lactate is a signal. By sticking notes on the engine parts, it tries to help the heart adapt to the crisis.

The Takeaway

This research suggests that instead of just trying to remove all the lactate, doctors might be able to tweak how the heart handles it. By managing how these "sticky notes" are placed (specifically by controlling the MCT1 gate), we might be able to reduce scarring and help the heart recover better after a heart attack. It turns out the engine has a hidden "plasticity"—the ability to bend and adapt to survive—waiting to be unlocked.

Technical Summary

Technical Summary: Lactylation Landscape of Mitochondrial Proteins in Myocardial Infarction

1. Problem Statement

Myocardial infarction (MI) triggers a profound metabolic reprogramming in cardiomyocytes, characterized by a shift from fatty acid oxidation to anaerobic glycolysis. This shift results in significant lactate accumulation and subsequent mitochondrial dysfunction. While lysine lactylation (Kla) has recently been identified as a metabolic signaling mechanism linking cellular metabolism to gene regulation, its specific role, landscape, and functional consequences within mitochondria during the context of MI remain poorly understood. The central question is whether mitochondrial lactylation acts merely as a pathological marker of metabolic stress or serves as a regulatory mechanism influencing mitochondrial bioenergetics, redox homeostasis, and tissue remodeling.

2. Methodology

The study employed a multi-faceted approach combining systems biology, pharmacology, and genetic manipulation:

• Quantitative Proteomics: The researchers performed a comprehensive mapping of the mitochondrial lactylome (the complete set of lactylated proteins) in models of MI to identify specific sites and proteins undergoing modification.
• Pharmacological Intervention: To probe the causal relationship between lactate transport and lactylation, the study utilized AZD3965, a specific inhibitor of Monocarboxylate Transporter-1 (MCT1), which regulates lactate influx/efflux.
• In Vivo and In Vitro Models:
  • In vivo: MI models were treated with AZD3965 to assess global cardiac function, fibrosis, inflammation, and mitochondrial respiratory capacity.
  • In vitro: Hypoxic cardiomyocyte-derived cells were subjected to genetic or pharmacological MCT1 inhibition to isolate cellular mechanisms regarding reactive oxygen species (ROS) and enzyme activity.
• Functional Assays: Measurements included mitochondrial respiration, reactive oxygen species (ROS) levels, phosphorylation status of Pyruvate Dehydrogenase (PDH), and histological analysis of fibrosis and inflammation.

3. Key Contributions

• First Comprehensive Mitochondrial Lactylome in MI: The study defines the landscape of mitochondrial protein lactylation following myocardial infarction, identifying that this modification extensively remodels enzymes critical for bioenergetics, redox regulation, and metabolic control.
• Decoupling Lactate Transport from Global Dysfunction: The research demonstrates that modulating lactate transport via MCT1 inhibition reshapes the lactylome in a specific manner, increasing lactylation on select metabolic and redox proteins without causing uniform mitochondrial collapse.
• Mechanistic Insight into Metabolic Plasticity: It establishes that mitochondrial lactylation is not solely a pathological byproduct but a context-dependent regulator that integrates lactate availability with mitochondrial function to modulate inflammatory and fibrotic outcomes.

4. Key Results

• Proteomic Remodeling: MI induces extensive changes in the mitochondrial lactylome, affecting key enzymes involved in energy production and oxidative stress management.
• Effects of MCT1 Inhibition (AZD3965):
  • Lactylome Reshaping: Inhibition of MCT1 altered the mitochondrial lactylome, specifically increasing lactylation on proteins associated with metabolism and redox balance.
  • Mitochondrial Function: Contrary to the expectation that blocking lactate transport would worsen mitochondrial stress, MCT1 inhibition partially restored mitochondrial respiratory capacity.
  • Cellular Protection: In hypoxic cardiomyocytes, MCT1 inhibition (genetic or pharmacological) led to:
    • Reduced mitochondrial Reactive Oxygen Species (ROS).
    • Decreased inhibitory phosphorylation of Pyruvate Dehydrogenase (PDH), thereby promoting the conversion of pyruvate to acetyl-CoA and improving bioenergetics.
• Tissue-Level Outcomes: Despite the persistence of some global cardiac functional impairment, MCT1 inhibition significantly attenuated post-MI fibrosis and inflammation.

5. Significance

This study fundamentally shifts the understanding of lactylation in ischemic heart disease. It posits that mitochondrial lactylation acts as a sophisticated signaling mechanism that couples metabolic state (lactate levels) to mitochondrial function.

• Therapeutic Implication: Rather than viewing lactate accumulation and lactylation purely as detrimental, the findings suggest that modulating lactate transport (via MCT1) can harness mitochondrial metabolic plasticity to reduce oxidative stress and tissue remodeling.
• New Target: The research highlights mitochondrial metabolic plasticity and the MCT1-lactylation axis as promising therapeutic targets for mitigating fibrosis and inflammation in ischemic heart disease, offering a potential strategy to improve outcomes beyond standard reperfusion therapies.